STAR MS: Single Test to ARrive at MS diagnosis; a prospective, investigator blinded pilot study assessing the accuracy of the ´Central Vein Sign´ using a single 3T MRI scan in diagnosing MS in cases of diagnostic uncertainty (NCT02485223)
ECTRIMS Online Library, Margareta Clarke, 228494
Applicability of neuromyelitis optica spectrum disease clinical trial attack criteria in a clinical routine setting - a trial design
ECTRIMS Online Library, Marcus D'Souza, 228495
Neurofilament light chain is a useful biomarker in paediatric multiple sclerosis
ECTRIMS Online Library, Jutta Gärtner, 228510
Serum neurofilament light chain in pediatric acquired demyelinating syndromes
ECTRIMS Online Library, Arlette Bruijstens, 228511
Social deprivation increases risk of disability in relapsing-remitting and secondary progressive MS
ECTRIMS Online Library, Floriane Calocer, 228526
Epidemiology of NMOSD in Central Serbia
ECTRIMS Online Library, Jelena Drulovic, 228527
Validation of the Fitbit Flex2 accelerometer to measure step count in people with MS during 7 days of continuous remote monitoring in the home environment
ECTRIMS Online Library, Valerie J Block, 228542
Electronic Neurostatus-EDSS increases quality of expanded disability status scale (EDSS) assessments: first experience from two phase 3 clinical trials with ofatumumab in relapsing multiple sclerosis using the Web Diary
ECTRIMS Online Library, Marcus D'Souza, 228543
A mobile application for real-time assessment of fatigue and related symptoms in patients with multiple sclerosis
ECTRIMS Online Library, Miklos Palotai, 228558
Sick leave in early MS is associated with fatigue and relapse rate, not disability
ECTRIMS Online Library, Djoeke Doesburg, 228559
Relapsing-remitting multiple sclerosis and subclinical atherosclerosis
ECTRIMS Online Library, Tomaž Omerzu, 228574
The prevalence of comorbidities before and after the onset of multiple sclerosis compared to the general population
ECTRIMS Online Library, Ingrid van der Mei, 228575
Epigenetic mechanisms regulate T helper 17 and T regulatory cells during pregnancy in multiple sclerosis
ECTRIMS Online Library, Simona Rolla, 228590
Multiple sclerosis-associated IL2RA gene variants affect DNA methylation
ECTRIMS Online Library, Helle Bach Søndergaard, 228591
Distinct effects of inflammatory mediators linked to inflammatory multiple sclerosis on neuronal damage and regeneration in human neuronal stem cell-derived neuron cultures
ECTRIMS Online Library, Lil Meyer-Arndt, 228606
Multiple sclerosis associated cytotoxic CD4+ T cells escape regulatory T cell mediated suppression
ECTRIMS Online Library, Bieke Broux, 228607
Chitinase 3-like 1 as potential therapeutic target in multiple sclerosis
ECTRIMS Online Library, Clara Matute-Blanch, 228622
Clostridium perfringens epsilon toxin: a putative MS microbiological trigger that causes focal demyelination with axonal preservation
ECTRIMS Online Library, Paige Winokur, 228623
Accelerating cortical atrophy as an explanation for cognitive decline in progressive MS
ECTRIMS Online Library, Anand JC Eijlers, 228638
Disappearing lesions after a clinically isolated syndrome
ECTRIMS Online Library, Rosa Cortese, 228639
Lesion-seeded MRI diffusion streamline analysis detects pathology in MS lesion edges
ECTRIMS Online Library, Olayinka Oladosu, 228654
Open-label, single-blinded, observational, prospective, 24-month, longitudinal, controlled study to assess the efficacy of fingolimod on development of thalamus pathology and cognitive impairment in patients with relapsing forms of multiple sclerosis
ECTRIMS Online Library, Robert Zivadinov, 228655
Grey matter connectivity changes in patients with multiple sclerosis after a neurorehabilitation program
ECTRIMS Online Library, deborah pareto, 228670
q-Space Myelin Map imaging for longitudinal analysis of remyelination in multiple sclerosis patients treated with natalizumab
ECTRIMS Online Library, Kenji Kufukihara, 228671
Disease modifying drug treatment and work functioning in patients with multiple sclerosis
ECTRIMS Online Library, Karin van der Hiele, 228686
A game-changer for treating cognitive impairment in MS? Feasibility and preliminary efficacy of an in-home, unsupervised videogame-based digital therapeutic
ECTRIMS Online Library, Riley Bove, 228687
Face-to-face and telematics cognitive stimulation in multiple sclerosis patients
ECTRIMS Online Library, Marta Cerezo-García, 228688
Utility of cerebrospinal fluid free light kappa and lambda chain determination in oligoclonal band-negative patients with suspected multiple sclerosis
ECTRIMS Online Library, Diana Ferraro, 228703
Temporal changes of inflammation and endothelial dysfunction in multiple sclerosis related to the evolution of enhancing lesions on frequent MRI
ECTRIMS Online Library, Zsolt Illes, 228704
Transcriptomic effect of fingolimod on B cell differentiation and survival in multiple sclerosis patients and the relationship with NEDA response. Not everything is explained by lymphocyte retention
ECTRIMS Online Library, Irene Moreno Torres, 228705
Equipoise for randomizing RRMS patients to escalation vs highly effective treatment in a large clinical cohort
ECTRIMS Online Library, Marisa McGinley, 228719
Recurring symptoms at the end of the natalizumab cycle: can we explain the wearing-off effect?
ECTRIMS Online Library, Zoé L.E. van Kempen, 228720
Immunomodulation associated with clinical and MRI worsening in patients with progressive MS treated with MD1003 (high dose pharmaceutical grade biotin)
ECTRIMS Online Library, Beatrice Pignolet, 228721
Lymphopenia rates in CLARITY/CLARITY extension are unrelated to disease activity at baseline
ECTRIMS Online Library, Stuart Cook, 228735
Blood transcriptome analysis of alemtuzumab-treated MS patients from the CARE-MS I and II studies
ECTRIMS Online Library, Mindy Zhang, 228736
Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY extension
ECTRIMS Online Library, Gavin Giovannoni, 228737
Real-world data from over 10 years in the TYSABRI® Observational Program: long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients
ECTRIMS Online Library, Ludwig Kappos, 228751
7-year outcomes in MS patients of African descent treated with alemtuzumab: follow-up of CARE-MS I and II (TOPAZ Study)
ECTRIMS Online Library, Mitzi Williams, 228752
Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial
ECTRIMS Online Library, Jerry Wolinsky, 228753
Longitudinal stability of anti-JC virus antibody index over two years in patients treated with natalizumab in the ASCEND study
ECTRIMS Online Library, Louise Mason, 228767
Infection risks among Swedish multiple sclerosis patients treated with rituximab compared to natalizumab, fingolimod, and injectable therapies: a nationwide cohort study
ECTRIMS Online Library, Thomas Frisell, 228768
Sex differences in the pivotal MS clinical trials: what is the evidence?
ECTRIMS Online Library, Riley Bove, 228769
Remyelination in the optic nerve detected by visual evoked potentials
ECTRIMS Online Library, Ian Duncan, 228784
Relationship between overall response score of disability in MS with patient-reported outcome SF-36
ECTRIMS Online Library, Ih Chang, 228785
Patient-reported SymptoMScreen baseline scores in patients with relapsing-remitting multiple sclerosis enrolled in Phase IIIb studies of ocrelizumab (ENSEMBLE and CASTING)
ECTRIMS Online Library, Ilya Kister, 228786
Application of a modified ketogenic diet in relapsing-remitting multiple sclerosis: a pilot study
ECTRIMS Online Library, J. Nicholas Brenton, 228801
Therapeutic inertia in multiple sclerosis care: a comparative study between Spain and Chile
ECTRIMS Online Library, Gustavo Saposnik, 228802
Normalization of butyrate-producing Faecalibacterium after 12 weeks intervention with delayed-release dimethyl fumarate in multiple sclerosis
ECTRIMS Online Library, Trygve Holmøy, 228803
Welcome and introduction
ECTRIMS Online Library, Hans-Peter Hartung, 231860
Treating disease activity earlier: Evidence for long-term benefits
ECTRIMS Online Library, Mar Tintore, 231861
Ocrelizumab: From clinical trial data to longer-term outcomes
ECTRIMS Online Library, Andrew Chan, 231862
Clinical perspectives: Putting early, effective treatment into clinical practice
ECTRIMS Online Library, Rob Bermel, 231863
ECTRIMS Online Library, Session Speakers, 231864
Committing to generations, impacting patients: advancing disease management across the continuum of MS
ECTRIMS Online Library, Session Speakers, 234393
Treatment of PML and other opportunistic infections
ECTRIMS Online Library, Joseph Berger, 231829
Mortality rates in large US and Swedish rituximab-treated multiple sclerosis cohorts
ECTRIMS Online Library, Annette Langer-Gould, 231830
Cancer risk among Swedish multiple sclerosis patients: a nationwide cohort study comparing rituximab, fingolimod and natalizumab
ECTRIMS Online Library, Peter Alping, 231831
Severe encephalitis and meningoencephalitis with systemic symptoms after daclizumab therapy for multiple sclerosis
ECTRIMS Online Library, Imke Metz, 231832
Monitoring CNS inflammatory activity in natalizumab related PML with TSPO-PET
ECTRIMS Online Library, Christoph Mahler, 231833
ECTRIMS Online Library, Emmanuelle Waubant, 231834
ECTRIMS Online Library, Jiwon Oh, 231836
Potential of exercise and cognitive training
ECTRIMS Online Library, Iris-Katharina Penner, 231837
Cognitive rehabilitation and neuroimaging
ECTRIMS Online Library, John DeLuca, 231838
Damage to long-range connections is especially relevant for cognitive impairment in multiple sclerosis
ECTRIMS Online Library, Kim A Meijer, 231839
Early focal inflammatory disease is associated with long-term cognitive performance in relapse-onset multiple sclerosis
ECTRIMS Online Library, Wallace Brownlee, 231840
Cognitive processing speed assessment in clinical practice: clinical, patient reported outcome, and quantitative MRI correlations
ECTRIMS Online Library, K. Nakamuk, 231841
The effect of depression and bipolar disorder on multiple sclerosis disability worsening
ECTRIMS Online Library, Stefanie Binzer, 231842
Immunological phenotyping identifies MS patients with accentuated immune cell activation upon anti-CD20 treatment
ECTRIMS Online Library, Silke Häusser-Kinzel, 231843
Cladribine personalised dosing in people with MS (n>200) - four years experience in clinical care
ECTRIMS Online Library, Stefania De Trane, 231844
Importance of CD4+CCR5+ effector memory cells for immune surveillance
ECTRIMS Online Library, Sebastian Herich, 231845
Aquaporin-4-IgG seropositivity is associated with worse visual outcomes after optic neuritis, independent of inner retinal layer thinning and microcystic macular pathology
ECTRIMS Online Library, Elias S. Sotirchos, 231846
Vitreous haze as a novel marker for neurodegeneration in MS possibly indicating impairment of the retinal glymphatic system
ECTRIMS Online Library, Danko Coric, 231847
A nurse-led research to improve the tolerability of alemtuzumab by reducing peri-infusional reactions
ECTRIMS Online Library, Clara Maria Oriol, 231850
NMOSD and related autoantibody CNS disorders
ECTRIMS Online Library, Aksel Siva, 231851
Atypical inflammatory syndromes of the CNS
ECTRIMS Online Library, Mark Keegan, 231852
Primary and secondary inflammatory vasculopathies and other inflammatory disorders of the CNS mimicking MS
ECTRIMS Online Library, Claire Rice, 231853
General considerations in biomarker research and application
ECTRIMS Online Library, Bernhard Hemmer, 231854
Serum and CSF biomarkers in MS
ECTRIMS Online Library, Manuel Comabella, 231855
Basics of MS genetics
ECTRIMS Online Library, Sergio E. Baranzini, 231856
What have we learnt on remyelination in MS? an historical perspective
ECTRIMS Online Library, Catherine Lubetzki, 231857
Promoting exogenous remyelination: from basic sciences to translation
ECTRIMS Online Library, Steven Goldman, 231858
Promoting endogenous remyelination: from basic sciences to translation
ECTRIMS Online Library, Ari Green, 231859
What should be imaged in progressive MS: the lesson from pathology
ECTRIMS Online Library, Hans Lassmann, 231817
Understanding progression: a PET imaging perspective
ECTRIMS Online Library, Bruno Stankoff, 231819
Cytoskeletal breakdown during axon injury in a mouse model of neuromyelitis optica
ECTRIMS Online Library, Marina Herwerth, 231820
Mucosal addressin cell adhesion molecule 1 mediated intestinal lymphocyte homing is critical for the development of experimental autoimmune encephalomyelitis
ECTRIMS Online Library, Kristina Kuhbandner, 231821
Vitamin D augments glucocorticosteroid efficacy via inhibition of mTORc1
ECTRIMS Online Library, Maud Bagnoud, 231822
A novel β1-integrin/KV1.3 -mediated vesicular glutamate release pathway in Th17 cells
ECTRIMS Online Library, Katharina Birkner, 231823
The oligodendroglial differentiation block in multiple sclerosis- mediated by intrinsic or extrinsic factors?
ECTRIMS Online Library, Laura Starost, 231824
Digital solutions that support MS nursing care
ECTRIMS Online Library, Rachel Morrison, 231825
Adolescent transition - lessons from two specialist centres
ECTRIMS Online Library, Katie Hanson, 231826
Digital care programme NeuroResponse
ECTRIMS Online Library, Bernadette Porter, 231827
Efficacy in the real world
ECTRIMS Online Library, Tomas Kalincik, 231796
Traps and pitfalls (methodological issues)
ECTRIMS Online Library, Maria Pia Sormani, 231797
Multiple sclerosis in Germany 2018 - update on baseline data from the German MS Registry
ECTRIMS Online Library, Peter Flachenecker, 231798
Prognosis, response to therapy and treatment effect: easy to say, hard to measure
ECTRIMS Online Library, Maria Pia Sormani, 231810
Neuropathological injury in MS and relationship to structural MRI metrics
ECTRIMS Online Library, Jeroen Geurts, 231811
Functional MRI studies in MS: update on brain plasticity and repair
ECTRIMS Online Library, Christian Enzinger, 231812
Functional relevance of MRI in early MS, correlation with cognitive performance and related outcomes
ECTRIMS Online Library, Bruno Brochet, 231813
Unraveling the cause of neuronal mitochondrial dysfunction in MS
ECTRIMS Online Library, Don Mahad, 231814

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings